INTERNATIONAL BUSINESS MACHINES CORP (IBM): what the price requires

At today's price, INTERNATIONAL BUSINESS MACHINES CORP (IBM) is priced for today's economics sustained for ~5.1 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-13 · Source: https://boothcheck.com/report/IBM

Headline

FieldValue
TickerIBM
CompanyINTERNATIONAL BUSINESS MACHINES CORP
Current price$291.03/sh
CompositionHybrid Cloud 11% / Automation 11% / Data 9% / Transaction Processing 13% / Strategy and Technology 17% / Intelligent Operations 14% / Hybrid Infrastructure 16% / Infrastructure Support 8% / Financing 1% / Other 0%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin needed15.6%
Operating margin today11.9%
Margin expansion implied+3.7pp
Must persist for5.1y
Multiple paid44x operating income

The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.

Solve inputs: computed at a 7.5% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.2 years.

Reconcile: at the x-ray's 9.3% required return this reads ~8.9 years; the models below use their own rates.

How unusual the bet is: high

ReferenceValue
vs own history+5.04σ
cohort percentile (of 177 peers)72
sustained it ~5.1 years at this level33%
implied end-window share1%

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset2.48x4expensive
Earnings3.20x4expensive
Relative0.95x4justifies
Growth0.83x3justifies

Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.5%); the inversion above states its own rate.

Per-Model Detail (n=15)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$413.250.70xyesFCF base $13.5B, growth 10% (input: historical growth), terminal g 4.0%, WACC 7.5%, 6yr projection
DCF Exit MultipleGrowth$349.910.83xyesExit EV/EBITDA: 603.6x / 605.6x / 607.6x (bear / base = today's held flat / bull), 6yr
Relative ValuationRelative$278.321.05xyesP/E 28x (sector median), scenarios: 23.4x / 28.0x / 32.6x (bear / base = sector held flat / bull), EV/EBITDA 44x
Simple DDMGrowth——no—
Two-Stage DDMGrowth——no—
Simple Excess ReturnAsset$98.032.97xyesBV/sh $34.63, ROE (TTM) 26.2%, ke 9.3%
Two-Stage Excess ReturnAsset$166.691.75xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$251.771.16xyesRev $68.9B, growth 10% (input: historical growth; tapered), Terminal P/S: 3.4x / 4.0x / 4.7x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$109.022.67xyesEPS $9.08, growth 2% (input: historical EPS growth), PEG=17.52 (Overvalued)
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings——no—
Residual IncomeAsset$146.131.99xyesBV $34.63 + 5yr PV of (ROE (TTM) 26.2% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$84.143.46xyes√(22.5 × EPS $9.08 × BVPS $34.63) — Graham's conservative floor
EV/EBITDA RelativeRelative$0.0129103.00xyesEBITDA $0.56B × sector EV/EBITDA 20.0x (excluded from median)
FCF YieldEarnings$84.673.44xyesFCF $12913.0M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$64.014.55xyesSBC-adj FCF $11.09B (FCF $12.91B − SBC $1.82B) capitalized at Kₑ
Ben Graham FormulaEarnings$293.130.99xyesEPS $9.08 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative$434.250.67xyesRevenue $68.91B × sector P/S 6.0x
PEG Fair ValueRelative$340.670.85xyesEPS $9.08 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$98.212.96xyesEPS $9.08 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Net debt$55.7b
Net debt / NOPAT (after-tax)8.40x
Net debt / operating income (pre-tax)7.36x
Interest coverage3.9x
Share count CAGR (dilution)1.2%
Burning cashno

Bullet Takeaways

Bull Case

Read where the price sits against the methods and IBM looks less stretched than its reputation suggests. At $249.01 (as of June 27, 2026), the price is defended by the peer-multiple and forward-growth lenses, which land near and above the price, while only the static asset and earnings-power lenses say expensive. That split is the signature of a business whose value lives in forward earnings power rather than book value, which is exactly what a software company should look like. The relative-valuation method, anchored on a sector earnings multiple, lands near $278, and the growth-adjusted earnings methods land in the $290-to-$340 range, all above today's price. The market is not paying a frothy multiple for IBM; it is paying a software multiple for a company that has become a software company.

The transformation is real in the numbers, not just the narrative. In fiscal 2025 the Software segment produced $29,962 million of revenue at an 83.5% gross margin. Software gross margins above 80% are the highest-quality revenue in technology, and they now anchor the portfolio. Total reportable-segment profit reached $16,364 million on $67,472 million of segment revenue, and the first quarter of 2026 carried the momentum forward: software revenue grew 11.3%, led by Red Hat up 13% and Data up 19%, while consulting grew 4% and total revenue rose 9.5% to $15.9 billion. The hybrid-cloud and AI franchises, Red Hat as the open-source layer and watsonx plus mainframe-based AI inferencing on top, give IBM a position in enterprise AI that sits alongside the hyperscalers rather than competing head-on with them.

Cash generation is the bull case's anchor, and it is improving. IBM produced about $12.9 billion of trailing free cash flow, and management reported its highest first-quarter free cash flow in a decade, reiterating full-year 2026 guidance for over 5% revenue growth at constant currency and roughly a $1 billion increase in free cash flow. Return on equity runs about 26% on a book of $34.63 per share, evidence that the software-weighted business earns well on its capital. That cash funds a substantial dividend and the acquisitions that keep the software portfolio current, including the $11.6 billion purchase of Confluent to add real-time data streaming, a deal IBM had signaled in its own 10-K. The bull case is that an 83%-gross-margin software engine throwing off record cash deserves the multiple the market is paying.

Bear Case

Name the competitors, because they are larger and faster. IBM's hybrid-cloud and AI strategy puts it in the same arena as the hyperscalers, Microsoft, Amazon, and Google, whose cloud platforms carry deeper balance sheets, faster organic growth, and a stronger gravitational pull on enterprise AI workloads. IBM's screened hardware peers, Cisco, Dell, and HP, are the legacy neighborhood it is trying to leave behind, but the company it most needs to outrun is not on that list. The bear case is that IBM is a credible enterprise-software player growing software at low double digits, while the platforms it competes with grow faster and define the AI roadmap. Red Hat and watsonx are genuine assets, but IBM is a participant in the AI buildout, not a leader of it, and the price increasingly assumes it can hold its ground against companies expanding theirs.

The balance sheet is where the transformation gets expensive. Net debt sits at about $56 billion, more than seven times trailing operating income, with interest coverage of roughly 3.9 times, and IBM keeps adding to the load through acquisitions: the $11.6 billion Confluent purchase is the latest in a string of deals used to refresh the software portfolio. A meaningful portion of that debt supports the Financing segment and is not pure corporate leverage, but the company is buying growth rather than generating all of it organically, and acquisition-led growth carries integration risk, intangible amortization that suppresses reported earnings, and the standing question of what happens when the deal pipeline pauses. The consulting business, $5.3 billion in the quarter, grew only 4%, a reminder that a large slice of IBM is still a services business with services-business growth.

The valuation methods that say expensive are the ones worth taking seriously here. The earnings-power and asset lenses, which capitalize current profit and read book value, land well below the price, near $84 to $166 per share on the credible models. The forward-growth and peer-multiple lenses that defend the price do so by crediting continued double-digit software growth for roughly seven years, and the priced-in assumption reads as high relative to history: the durability of that software growth is the entire bet. If software growth slows toward the consulting segment's mid-single-digit pace, or if the hyperscalers pull more enterprise AI spend onto their platforms, the multiple the relative methods rely on compresses toward the sector and the static methods become the relevant anchor. IBM has executed a genuine turnaround; the bear case is that the price now assumes the turnaround keeps accelerating rather than maturing.

Valuation

The price is best read on the segments, because IBM is a portfolio of businesses with very different economics. The embedded assumption is roughly seven years of continued elevated growth in the highest-margin parts of that portfolio, principally software. That is a durability bet on the software franchise rather than a margin-expansion bet, and it reads as high relative to what a company IBM's size and age typically sustains, but it is anchored on real, demonstrated software momentum rather than a speculative leap.

How far the price sits from the methods depends entirely on which part of IBM you weight. The peer-multiple and forward-growth lenses defend the price: the relative-valuation method lands near $278 on a sector earnings multiple, and the growth-adjusted earnings methods land in the $290-to-$340 range, all at or above $249.01. The static lenses say expensive: the earnings-power and zero-growth cash-flow methods land near $64 to $98 per share, and the asset methods near $84 to $166. The pattern is clear and coherent, the price is justified by what IBM is becoming, a software-and-AI company worth a software multiple, and looks rich against what it earned as a legacy hardware-and-services company. The right comparison is the software-weighted forward lens, and on that lens the price is reasonable; the static lenses simply cannot value an 83%-gross-margin software engine on its trailing asset base.

Solvency is the place to temper the optimism. Net debt of about $56 billion is large, sitting at more than seven times trailing operating income with interest coverage near 3.9 times, though a meaningful share supports the Financing segment rather than the operating business. Free cash flow of roughly $12.9 billion comfortably covers the dividend and funds the acquisition cadence, and the share count has been roughly flat, with modest growth of about 1.2% a year. The decisive number for IBM is not a single valuation output; it is whether software keeps growing at double digits, because that growth is what makes the relative-multiple defense of the price hold and what services the debt the transformation has accumulated.

Catalysts

IBM reported first-quarter 2026 results on April 22, 2026, and beat on both lines. Revenue rose 9.5% year over year to $15.9 billion, ahead of consensus, and earnings per share of $1.91 exceeded the $1.81 forecast. Software was the engine, up 11.3% to $7.1 billion with Red Hat up 13% and Data up 19%, while consulting grew 4% to $5.3 billion. Free cash flow rose to its highest first-quarter level in a decade, and management emphasized mainframe-based AI inferencing as a driver of margin and cash-flow expansion.

The forward setup combines reaffirmed guidance with continued portfolio investment. Management reiterated its full-year 2026 view for over 5% revenue growth at constant currency and roughly a $1 billion increase in free cash flow. On the deal front, IBM completed its $11.6 billion acquisition of Confluent, adding real-time data streaming to its software stack, a transaction it had flagged in its annual filing. The watch items are the durability of double-digit software growth, the pace of Red Hat and Data, and whether the AI and hybrid-cloud positioning translates into share against faster-growing hyperscaler platforms, because that trajectory is what the price is paying for.

Peer Cohorts (Per Segment, With Filing Citations)

Software (reported)

Consulting (reported)

Infrastructure (reported)

Financing (reported)

Article Insight (Recent News Sentiment)

Sentiment score: 65.00 (MEDIUM confidence) FUD/Hype: HYPE_DETECTED (The article frames the post-earnings slide as an overreaction and emphasizes the potential of IBM's quantum and AI initiatives, leaning towards optimistic speculation.) Claim alignment: MIXED

The article suggests IBM’s recent price decline is an overreaction, emphasizing the undervaluation of its quantum and AI potential.

247wallst.com

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

IBM FY2025 10-K, accession 0000051143-26-000010 · IBM Q1 2026 earnings release, April 2026

View the full interactive IBM report on boothcheck